307 related articles for article (PubMed ID: 27358360)
1. Non-vitamin K oral anticoagulants in patients with atrial fibrillation after cardiac surgery: the results of the European Heart Rhythm Association Survey.
Vranckx P; Potpara T; Dagres N; Heidbuchel H
Europace; 2016 Jul; 18(7):1113-6. PubMed ID: 27358360
[TBL] [Abstract][Full Text] [Related]
2. Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey.
Larsen TB; Potpara T; Dagres N; Proclemer A; Sciarrafia E; Blomström-Lundqvist C;
Europace; 2015 May; 17(5):819-24. PubMed ID: 25926476
[TBL] [Abstract][Full Text] [Related]
3. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
Lip GY; Bongiorni MG; Dobreanu D; Lewalter T; Hastrup Svendsen J; Blomström-Lundqvist C;
Europace; 2013 Oct; 15(10):1526-32. PubMed ID: 24072770
[TBL] [Abstract][Full Text] [Related]
4. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
[TBL] [Abstract][Full Text] [Related]
5. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.
Hernández Madrid A; Potpara TS; Dagres N; Chen J; Larsen TB; Estner H; Todd D; Bongiorni MG; Sciaraffia E; Proclemer A; Cheggour S; Amara W; Blomstrom-Lundqvist C
Europace; 2016 Mar; 18(3):463-7. PubMed ID: 26899998
[TBL] [Abstract][Full Text] [Related]
6. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
[TBL] [Abstract][Full Text] [Related]
7. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.
Potpara TS; Pison L; Larsen TB; Estner H; Madrid A; Blomström-Lundqvist C;
Europace; 2015 Mar; 17(3):468-72. PubMed ID: 25722478
[TBL] [Abstract][Full Text] [Related]
8. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
[TBL] [Abstract][Full Text] [Related]
9. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.
Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Georg Haeusler K; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
Europace; 2018 Aug; 20(8):1231-1242. PubMed ID: 29562331
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
11. Patients' attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association.
Amara W; Larsen TB; Sciaraffia E; Hernández Madrid A; Chen J; Estner H; Todd D; Bongiorni MG; Potpara TS; Dagres N; Sagnol P; Blomstrom-Lundqvist C
Europace; 2016 Jan; 18(1):151-5. PubMed ID: 26462697
[TBL] [Abstract][Full Text] [Related]
12. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey.
Tilz RR; Potpara T; Chen J; Dobreanu D; Larsen TB; Haugaa KH; Dagres N
Europace; 2017 Oct; 19(10):1737-1742. PubMed ID: 29016910
[TBL] [Abstract][Full Text] [Related]
13. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.
Raparelli V; Proietti M; Cangemi R; Lip GY; Lane DA; Basili S
Thromb Haemost; 2017 Jan; 117(2):209-218. PubMed ID: 27831592
[TBL] [Abstract][Full Text] [Related]
14. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.
Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Eur Heart J; 2013 Jul; 34(27):2094-106. PubMed ID: 23625209
[TBL] [Abstract][Full Text] [Related]
15. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
16. Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P;
Eur Heart J; 2017 Jul; 38(27):2137-2149. PubMed ID: 27282612
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
18. What's New in Anticoagulation.
Razavi JE; Safavi-Naeini P; Razavi M
Tex Heart Inst J; 2016 Oct; 43(5):419-421. PubMed ID: 27777526
[No Abstract] [Full Text] [Related]
19. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
Garcia DA
Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
[TBL] [Abstract][Full Text] [Related]
20. Stroke and bleeding risk evaluation in atrial fibrillation: results of the European heart rhythm association survey.
Larsen TB; Potpara T; Dagres N; Pison L; Estner H; Blomström-Lundqvist C;
Europace; 2014 May; 16(5):698-702. PubMed ID: 24798958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
